FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/057463 [Registered on: 12/09/2023] Trial Registered Prospectively
Last Modified On: 06/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Efficacy of unani formulation in the treatment of Lichen Planus 
Scientific Title of Study   Clinical study of Lichen Planus and therapeutic evaluation of Unani formulation in its management 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Malik Nuzhat Fatima 
Designation  PG Scholar 
Affiliation  Ajmal khan tibbya College AMU 
Address  Department of Amraz e Jild wa Zohrawiya Ajmal khan tibbya college and hospital Faculty of Unani Medicine Aligarh Muslim University Aligarh

Aligarh
UTTAR PRADESH
202002
India 
Phone  8439778035  
Fax    
Email  maliknuzhat2015@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mohammad Mohsin 
Designation  Assosiate Professor 
Affiliation  Ajmal khan tibbya college AMU 
Address  Department of Amraz e Jild wa Zohrawiya Ajmal Khan tibbya college and hospital Faculty of Unani Medicine Aligarh Muslim University Aligarh

Aligarh
UTTAR PRADESH
202002
India 
Phone  9412329198  
Fax    
Email  aqdas2005@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Malik Nuzhat Fatima 
Designation  PG Scholar 
Affiliation  Ajmal khan tibbya college AMU 
Address  Department of Amraz e Jild wa Zohrawiya Ajmal Khan tibbya College and hospital Faculty of Unani medicine Aligarh Muslim University Aligarh

Aligarh
UTTAR PRADESH
202002
India 
Phone  8439778035  
Fax    
Email  maliknuzhat2015@gmail.com  
 
Source of Monetary or Material Support  
Department of Amraz e jild wa Zohrawiya Ajmal Khan Tibbya College Aligarh Muslim University Aligarh 
 
Primary Sponsor  
Name  Department of Amraz e Jild wa Zohrawiya  
Address  Department of Amraz e Jild wa Zohrawiya Near BSNL Office Aligarh Muslim University Aligarh 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Malik Nuzhat Fatima  Ajmal Khan Tibbya College and hospital  Department of Amraz e Jild wa Zohrawiya Ajmal Khan tibbya college and hospital Faculty of unani medicine AMU Aligarh
Aligarh
UTTAR PRADESH 
8439778035

maliknuzhat2015@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Ajmal Khan Tibbya College AMU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L438||Other lichen planus,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Deflazacort 6 milligram And Mometasone cream  Deflzacort 6 milligram one tablet twice a day for 15 days and Mometasone cream twice a day locally for 15 days 
Intervention  Majoon Musaffiye Aazam Marham e hina  Majoon Musaffiye Aazam (6gm) orally twice daily for 45 days and Marham e hina locally twice daily for 45 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Clinically diagnosed cases of Lichen Planus
Clinically stable patients
Patients of either sex
Patients having age group of 18 to 60 years
Patients who are willing to be a part of our study 
 
ExclusionCriteria 
Details  Patient below and above the age of 18 years and 60 years
Patients who are not willing to be a part of study
Patient suffering from any other type of skin diseases like psoriasis Eczema Seborrheic Dermatitis dermatophytosis and Lupus Erythematosus
Patient suffering from systemic and metabolic diseases like DM and prediabetes severe asthma Cardiac diseases Chronic Renal failure
History of taking Conventional and Alternative Medicine therapy of present disease within the previous 7 days
Pregnant & Lactating Women 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in Lichen Planus Severity Index
Improvement in Dermatology Life Quality Index.
Improvement in Photograph of affected area.  
Assessment of all parameters at inititation of the study at 0 day 15 day 30 day & 45 day of the study.  
 
Secondary Outcome  
Outcome  TimePoints 
Itching
Scaling
Violaceous, Hyperpigmented Papules 
Assessment of all the symptoms at initiation of the study at 0 day 15 day 30 day & 45 day of the study.  
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/09/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Lichen planus (LP) is a chronic inflammatory immune mediated disease that more frequently affects the skin and mucosa. Other areas that may be affected include the scalp, hair, nails and mucous membrane of the genitalia.Classic LP is characterized by violaceous, shiny, flat topped polygonal papules of variable sizes.Lichen planus is thought to be a T- cell mediated autoimmune disease, possibly targeting the basal keratinocyte. Exact Etiopathogenesis of LP is still unclear.The diagnosis of Lichen planus is clinical; however, it may be supplemented by histopathology.Aim of management of LP and its variants to control symptoms and to decrease time from onset to resolution. Treatment of cutaneous Lichen planus in conventional system of medicine is oral and topical corticosteroids, antihistamines, Vitamin A, Antibiotics and phototherapy /PUVA etc. 
There are some conditions mentioned in Unani system of medicine which has resemblance with lichen planus. It seems to be a type of Amraze Basoorat which is mentioned in almost all classical books.According to it’s clinical presentation it’s features mimics with the clinical presentation of basoor asfar and basoor aswad . The need of this study is to evaluate effectiveness of this classical unani preparation clinically, in this disease.

 
Close